Company Filing History:
Years Active: 1998
Title: Celebrating Innovator Anne Louise Jackson: A Pioneer in Leukocyte Analysis
Introduction: Anne Louise Jackson, an accomplished inventor based in Ridgefield, WA, is making significant contributions to the field of medical technology through her innovative work at Becton Dickinson and Company. With a focus on the preparation and analysis of leukocytes, her inventive methods are crucial for improving the accuracy of blood sample analysis.
Latest Patents: Anne Louise Jackson holds one notable patent: "Method for preparation and analysis of leukocytes in whole blood." This patent describes a method of flow cytometric analysis of leukocyte subpopulations using a fluorescence trigger and gating on light scatter versus fluorescence. This innovative approach proves invaluable when light scatter parameters fail to adequately identify leukocyte subpopulations, particularly in cases involving lysed blood samples where the removal of lysing reagents or unbound labels is not feasible prior to analysis.
Career Highlights: Throughout her career, Anne has demonstrated exceptional expertise and a commitment to advancing medical technologies. Her work at Becton Dickinson and Company Limited has positioned her as a leading figure in the field of flow cytometry, contributing to the development of tools that enhance diagnostic accuracy and patient care.
Collaborations: In her professional journey, Anne has collaborated with notable colleagues such as Robert A. Hoffman and Andrew D. Blidy. Together, they have worked to refine and advance the methodologies related to leukocyte analysis, showcasing the power of teamwork in driving innovation.
Conclusion: Anne Louise Jackson exemplifies the spirit of innovation within the scientific community. Her patent for a method of leukocyte analysis not only reflects her dedication and skill but also contributes significantly to the field of medical diagnostics. As she continues her work at Becton Dickinson and Company, her developments promise to enhance the future of blood analysis and patient outcomes.